• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ISLEEVE 14F; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ISLEEVE 14F; INTRODUCER, CATHETER Back to Search Results
Model Number 10445
Device Problem Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/13/2022
Event Type  malfunction  
Event Description
It was reported that failure to advance the introducer sheath within the artery occurred.Procedure summary the moderately calcified native aortic annulus was 21.7mm in diameter.Vascular access was obtained via a transfemoral approach.The access vessel was mildly tortuous with calcifications noted in the common iliac artery.A 14f isleeve introducer sheath was advanced to the bifurcation of the common iliac arteries and could not be advanced further due to circular calcifications in the abdominal aorta.An extra small (xs) safari2 guidewire was positioned.Balloon aortic valvuloplasty was performed with a 20mm non-boston scientific balloon catheter in accordance with the instructions for use (ifu).A size small acurate neo2 valve was prepared and loaded onto an acurate neo2 transfemoral (tf) delivery system (ds) in accordance with the ifu.The acurate neo2 tf ds was inserted but was not able to advance due to calcifications in the right common iliac artery.Contralateral access was obtained.The physician attempted unsuccessfully to dilate the vessel from the contralateral side to break up the calcifications in the vessel.The 14f isleeve was removed first, followed by the acurate neo2 tf ds.A vessel dissection was noted that was attributed to free cell protrusion on the acurate neo2 valve.A balloon catheter was placed above the dissection to stop the bleeding.The patient went into cardiac arrest, cardiopulmonary resuscitation was performed; however the patient condition did not improve.Patient status the patient died.
 
Manufacturer Narrative
H3: device eval by manufacturer: returned product consisted of the 14f isleeve introducer sheath with blood on/in the 14f isleeve introducer sheath.There were numerous kinks on the 14f isleeve introducer sheath.The 14f isleeve introducer sheath was buckled 14cm-16cm distal of the strain relief.All three seams of the 14f isleeve introducer sheath were found to be expanded, consistent with device usage as designed.The tip of the 14f isleeve introducer sheath was torn at the seams and damaged.Product analysis could not confirm the reported difficulty to advance, as the clinical circumstances were not able to be replicated.The damage to the 14f isleeve device is consistent with difficulty experienced during the procedure.
 
Event Description
It was reported that failure to advance the introducer sheath within the artery occurred.Procedure summary: the moderately calcified native aortic annulus was 21.7mm in diameter.Vascular access was obtained via a transfemoral approach.The access vessel was mildly tortuous with calcifications noted in the common iliac artery.A 14f isleeve introducer sheath was advanced to the bifurcation of the common iliac arteries and could not be advanced further due to circular calcifications in the abdominal aorta.An extra small (xs) safari2 guidewire was positioned.Balloon aortic valvuloplasty was performed with a 20mm non-boston scientific balloon catheter in accordance with the instructions for use (ifu).A size small acurate neo2 valve was prepared and loaded onto an acurate neo2 transfemoral (tf) delivery system (ds) in accordance with the ifu.The acurate neo2 tf ds was inserted but was not able to advance due to calcifications in the right common iliac artery.Contralateral access was obtained.The physician attempted unsuccessfully to dilate the vessel from the contralateral side to break up the calcifications in the vessel.The physician elected to retract the acurate neo2 tf ds through the 14 f isleeve introducer sheath.A vessel dissection was noted that was attributed to free cell protrusion on the acurate neo2 valve.A balloon catheter was placed above the dissection to stop the bleeding.The patient went into cardiac arrest, cardiopulmonary resuscitation was performed; however, the patient condition did not improve.Patient status: the patient died.It was further reported that the 14f isleeve was removed first, followed by the acurate neo2 tf ds.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISLEEVE 14F
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15668378
MDR Text Key307167098
Report Number2124215-2022-43432
Device Sequence Number1
Product Code DYB
UDI-Device Identifier08714729950660
UDI-Public08714729950660
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number10445
Device Catalogue Number10445
Device Lot Number0029846195
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/14/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/28/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age83 YR
Patient SexFemale
-
-